Author:
Suliburska Joanna,Bogdański Paweł,Szulińska Monika,Pupek-Musialik Danuta
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference41 articles.
1. Logue J, Murray HM, Welsh P, Shepherd J, Packard Ch, Macfarlane P, Cobbe S, Ford I, Sattar N (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart 97(7):564–568
2. Goodpaster BH, DeLany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTique K, Hames KC, Lang W, Jakicic JM (2010) Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304(16):1795–1802
3. de Lemos H, Atallah AN, de Lemos ALA (2008) Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis. Sao Paulo Med J 126(6):342–346
4. Smith IG, Goulder MA (2001) Sibutramine Clinical Study 1047 Team. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract 50(6):505–512
5. Svacina S, Owen K, Hendl J, Matoulek M, Brychta T (2007) Lipid lowering effect of sibutramine in statin treated patients comparison of lipid lowering effect of sibutramine in patients treated or not treated with statins—3 month follow-up. Prague Med Rep 108(4):333–338
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献